Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Personalis, Dovetail Genomics, DataDirect Networks, And More: News From April 2017

    Apr 27, 2017, 15:15 PM by Michael Croft
    Bio-IT World Brief | News, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Personalis, Dovetail Genomics, DataDirect Networks, and more.
    Full story
  • Record growth for life science tech firm as MES adoption increases globally

    Apr 27, 2017, 04:26 AM by Michael Croft
    - Apr 27, 2017 - A global life science technology firm has surpassed the €20 million milestone for sales of its manufacturing execution system (MES) services
    Full story
  • BioRxiv Preprint Server Gets Cash Boost From Chan Zuckerberg Initiative

    Apr 26, 2017, 15:47 PM by Michael Croft
    Nature News & Comment | Money will be used to develop open-source platform and help put articles in web-friendly formats.
    Full story
  • NovaSeq Orders Bring Pleasant Surprises, Says deSouza

    Apr 26, 2017, 10:45 AM by Michael Croft

    Bio-IT World Illumina held its first quarter earnings calls yesterday. Francis deSouza, President and CEO, reported that the launch of the company’s new sequencing platform, NovaSeq, “surpassed our expectations, with more than 135 orders in Q1.” “As far out as we can see, there’s an insatiable demand for high throughput sequencing,” deSouza said.  

    Full story
  • Four Decades Of Hacking Biotech And Yet Biology Still Consumes Everything

    Apr 26, 2017, 10:05 AM by Michael Croft
    Forbes | Computer-aided drug design is a key contributor to pharma R&D today, but its just one of many contributors. Biology still consumes everything, and is the real constraint on developing new medicines today. Healthy, realistic skepticism regarding recent "software-eats-biotech" claims is needed.
    Full story
  • Concept Life Sciences further expands its service offering by investing in Micro Chamber and Thermal Extraction Facilities

    Apr 26, 2017, 08:57 AM by Michael Croft
    MANCHESTER, UNITED KINGDOM - Apr 26, 2017 - Concept Life Sciences has further expanded its analytical testing capabilities by making significant investment into Micro Chamber and Thermal Extraction facilities, used to sample VOCs or SVOCs emitted from products and materials
    Full story
  • MR Solutions wins second Queen’s Award for Enterprise

    Apr 26, 2017, 08:55 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Apr 26, 2017 - MR Solutions, of Guildford has won the prestigious Queen’s Award for Enterprise for International Trade
    Full story
  • Future of Surfactants Summit North America

    Apr 26, 2017, 04:41 AM by Michael Croft
    CHICAGO, IL - Sep 27, 2017 - Future of Surfactants Summit North America, 27th & 28th September 2017, Chicago, ILThe Impact of Evolving Trends, Environmental Standards &Consumer Preferences on the Demand of Specialty Surfactants

    Following the success of our two European editions and inaugural North American version last year, we are pleased to announce the 2nd edition of our Future of Surfactants Summit North America will take place on the 27th & 28th September 2017, in Chicago, IL
    Full story
  • Genomenon Wins $1.8M NIH Grant To Automatically Curate Genomic Literature

    Apr 25, 2017, 16:25 PM by Michael Croft

    Bio-IT World Brief | Genomenon today announced a $1.8M grant awarded by the National Institutes of Health. The fast-track Small Business Innovation Research grant, awarded by the National Human Genome Research Institute, will fund Genomenon's further innovation in genomic analysis, efficiently streamlining the laborious literature research and curation process leading to faster patient diagnosis.

    Full story
  • Biotech Is The New Digital Says MIT Media Lab Founder

    Apr 25, 2017, 12:39 PM by Michael Croft
    Dezeen | Biotechnology is going to "govern the next decade of thought" at research institutions like the MIT Media Lab, says its founder Nicholas Negroponte.
    Full story
  • Recipharm appoints Henrik Stenqvist as new Chief Financial Officer

    Apr 25, 2017, 09:57 AM by Michael Croft
    STOCKHOLM, SWEDEN - Apr 11, 2017 - Recipharm AB today announced the appointment of Henrik Stenqvist as Recipharm’s new Executive Vice President and Chief Financial Officer, effective on April 24, 2017
    Full story
  • DNA Tests and Sometimes Surprising Results

    Apr 24, 2017, 10:40 AM by Michael Croft
    The New York Times | Think you know your racial background? A communications studies project involving ancestry DNA testing has led to interesting conversations on identity.
    Full story
  • Hannes Smarason On The Future Of The Platform For WuXi NextCODE

    Apr 24, 2017, 10:10 AM by Michael Croft
    Diagnostics World | Hannes Smarason, WuXi NextCode's new CEO, is looking to enable the use of the WuXi NextCode platform across a multitude of applications. The goal is to create a Contract Genomics Organization, an underlying platform for genomic data that brings together everything needed to empower healthcare.
    Full story
  • Biogen Says Its Back and Ready for ‘Highly Active’ Dealmaking

    Apr 24, 2017, 09:42 AM by Michael Croft
    Bloomberg | Biogen Inc. is ready to make some deals. "We're moving, and we're back in terms of augmenting the pipeline," research and development head Michael Ehlers said Friday in an interview. An agreement last week to pay Bristol-Myers Squibb Co. $300 million upfront for an experimental Alzheimer's drug is "hopefully just the beginning of a set of very rigorous but highly active deals."
    Full story
  • Recipharm opens new GMP suite for clinical trial material

    Apr 24, 2017, 09:26 AM by Michael Croft
    NORTH CAROLINA, NC - Apr 24, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina, USA
    Full story
  • Recipharm delivers first serialised batch to Saudi Arabia

    Apr 21, 2017, 11:50 AM by Michael Croft
    LISBON, PORTUGAL - Apr 21, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia, following the introduction of new regulatory requirements in March 2017
    Full story
  • World’s largest society for regulatory professionals increases investment in Europe

    Apr 21, 2017, 10:46 AM by Michael Croft
    - Apr 20, 2017 - The Regulatory Affairs Professionals Society (RAPS) is stepping up its presence in Europe and expanding its European team in response to growing membership demand from those involved with the regulation of healthcare and related products
    Full story
  • The Go-To Gene Sequencing Machine With Very Strange Results

    Apr 21, 2017, 10:31 AM by Michael Croft
    WIRED | An update to Illumina's gene sequencing technology could have contaminated the results of recent high-sensitivity data produced on the machines.
    Full story
  • Geisinger Accused Of Coercing Patients To Participate In Genetic Research

    Apr 20, 2017, 14:57 PM by Michael Croft
    PennLive.com | The Geisinger Health System has been accused by two of its former doctors of coercing patients to participate in genetic research. The accusation was made in a wrongful termination suit filed this week.
    Full story
  • Certara Introduces Comprehensive Solution to Prepare, Analyze and Submit Pharmacokinetic (PK) Data

    Apr 20, 2017, 09:43 AM by Michael Croft
    PRINCETON, NJ - Apr 19, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the launch of a new solution for preparing, analyzing and submitting PK data in Clinical Data Exchange Standards Consortium (CDISC) format
    Full story
  • «
  • 321
  • 322
  • 323
  • 324
  • 325 (current)
  • 326
  • 327
  • 328
  • 329
  • 330
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy